216 related articles for article (PubMed ID: 5818350)
21. [Mumps-antibody formation in guinea pigs following a single virus application. Evaluation of live mumps-virus vaccine].
Gladthe H; Abel C
J Hyg Epidemiol Microbiol Immunol; 1972; 16(2):202-7. PubMed ID: 5064723
[No Abstract] [Full Text] [Related]
22. [Vaccination against epidemic parotitis].
Midulla M; Chiavelli S
Pediatr Med Chir; 1984; 6(1):25-30. PubMed ID: 6442412
[TBL] [Abstract][Full Text] [Related]
23. In vitro and in vivo growth alter the population dynamic and properties of a Jeryl Lynn mumps vaccine.
Connaughton SM; Wheeler JX; Vitková E; Minor P; Schepelmann S
Vaccine; 2015 Aug; 33(36):4586-93. PubMed ID: 26187256
[TBL] [Abstract][Full Text] [Related]
24. Clinical and serological studies in Mexico with live attenuated mumps virus vaccine. (Jerry Lynn strain).
Ramos Alvarez M; Bessudo L
Rev Invest Salud Publica; 1972; 32(2):104-8. PubMed ID: 4584449
[No Abstract] [Full Text] [Related]
25. [Epidemic parotitis in Italy: results of a 1st vaccination trial].
Midulla M; Tamburello O; Balducci L; Assensio AM; Finocchiaro M; Chicca A; Sabatino G
Ann Sclavo; 1977; 19(2):177-86. PubMed ID: 603264
[TBL] [Abstract][Full Text] [Related]
26. Studies on live mumps virus vaccine. IV. Clinical and serological follow-up 2 year and 3 years after vaccination.
Yamanishi K; Takahashi M; Kurimura T; Ueda S; Suzuki N
Biken J; 1971 Sep; 14(3):259-65. PubMed ID: 5156905
[No Abstract] [Full Text] [Related]
27. Experience with live-virus mumps vaccine.
J Iowa Med Soc; 1968 Sep; 58(9):955-7. PubMed ID: 5683277
[No Abstract] [Full Text] [Related]
28. Pathogenicity of mumps virus in the marmoset.
Saika S; Kidokoro M; Ohkawa T; Aoki A; Suzuki K
J Med Virol; 2002 Jan; 66(1):115-22. PubMed ID: 11748667
[TBL] [Abstract][Full Text] [Related]
29. [Adverse effects following vaccinations and effectiveness of different live vaccines against mumps].
Magdzik W; Zieliński A
Przegl Epidemiol; 2002; 56(3):377-89. PubMed ID: 12608087
[TBL] [Abstract][Full Text] [Related]
30. Experiences with Jeryl Lynn strain live attenuated mumps virus vaccine in a pediatric outpatient clinic.
Young ML; Dickstein B; Weibel RE; Stokes J; Buynak EB; Hilleman MR
Pediatrics; 1967 Nov; 40(5):798-803. PubMed ID: 6075651
[No Abstract] [Full Text] [Related]
31. [Functional state of specific immunity in children and teenagers vaccinated against mumps].
Otrashevskaia EV; Bukin EK; Krasil'nikov IV; Ignat'ev GM
Vopr Virusol; 2010; 55(4):20-5. PubMed ID: 20886708
[TBL] [Abstract][Full Text] [Related]
32. A plaque neutralization test for determining mumps antibodies.
Ennis FA; Douglas RD; Stewart GL; Hopps HE; Meyer HM
Proc Soc Exp Biol Med; 1968 Dec; 129(3):896-9. PubMed ID: 5725114
[No Abstract] [Full Text] [Related]
33. Mumps outbreaks in vaccinated populations: are available mumps vaccines effective enough to prevent outbreaks?
Dayan GH; Rubin S
Clin Infect Dis; 2008 Dec; 47(11):1458-67. PubMed ID: 18959494
[TBL] [Abstract][Full Text] [Related]
34. Protection of mumps in children with various underlying diseases: application of a live attenuated mumps and trivalent measles-rubella-mumps (MRM) vaccines in these children.
Kanesaki T; Baba K; Tsuda N; Yabuuchi H; Yamanishi K; Takahashi M
Biken J; 1986 Dec; 29(3-4):63-71. PubMed ID: 3304276
[TBL] [Abstract][Full Text] [Related]
35. Live, attenuated mumps-virus vaccine.
Hilleman MR; Buynak EB; Weibel RE; Stokes J
N Engl J Med; 1968 Feb; 278(5):227-32. PubMed ID: 4169706
[No Abstract] [Full Text] [Related]
36. Combined live rubella-mumps virus vaccine. Findings in clinical-laboratory studies.
Weibel RE; Stokes J; Villarejos VM; Arguedas JA; Buynak EB; Hilleman MR
JAMA; 1971 May; 216(6):983-6. PubMed ID: 5108387
[No Abstract] [Full Text] [Related]
37. [Community effectiveness of vaccines against infectious parotiditis (mumps). Report of cases].
Limón Mora J; Molina López T; Domínguez Camacho JC
Rev Esp Salud Publica; 1999; 73(4):455-64. PubMed ID: 10575934
[TBL] [Abstract][Full Text] [Related]
38. [Mumps: efficacy of booster immunization].
Gassner M; Hess U; Berger R
Schweiz Med Wochenschr; 1995 Dec; 125(51-52):2506-10. PubMed ID: 8571103
[TBL] [Abstract][Full Text] [Related]
39. [Antibody formation following immunization with mono- and bivalent mumps-(measles-)vaccine (author's transl)].
Sarateanu DE; Allerdist H; Ehrengut W
Immun Infekt; 1978 Feb; 6(1):33-7. PubMed ID: 627405
[TBL] [Abstract][Full Text] [Related]
40. [Wide-spread inflammation of the parotid glands (mumps): an underestimated disease. II. Development, use, efficacy and safety of mumps vaccines].
Gałazka A; Kraigher A; Robertson SE
Przegl Epidemiol; 1998; 52(4):401-12. PubMed ID: 10321084
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
